
Olivia Kim-McManus, MD, discusses how personalized antisense therapy reduced seizures and improved development in 2 children with SCN2A-related developmental epileptic encephalopathy.

Olivia Kim-McManus, MD, Child neurologist, Rady Children’s Hospital-San Diego; Associate clinical professor, Neurosciences, Pediatric Neurology, Epilepsy & Clinical Neurophysiology, UC San Diego School of Medicine Department of Neurosciences.

Olivia Kim-McManus, MD, discusses how personalized antisense therapy reduced seizures and improved development in 2 children with SCN2A-related developmental epileptic encephalopathy.

"What is the possibility for your individual child that you're taking care of as a patient, as a family member advocate?" said Oliva Kim-McManus, MD.

In this interview from the 2025 Child Neurology Society meeting, Olivia Kim-McManus explains how far the gene therapy and genetic testing space has come related to pediatric neurology.